Format
Sort by
Items per page

Send to

Choose Destination

Best matches for "alefacept" AND ("allogenic solid organ transplantation" OR "chronic plaque psoriasis"):

Search results

Items: 1 to 20 of 77

  • Quoted phrase not found.
1.

Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.

Sbidian E, Chaimani A, Garcia-Doval I, Do G, Hua C, Mazaud C, Droitcourt C, Hughes C, Ingram JR, Naldi L, Chosidow O, Le Cleach L.

Cochrane Database Syst Rev. 2017 Dec 22;12:CD011535. doi: 10.1002/14651858.CD011535.pub2. Review.

2.

Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?

Zaidi A, Meng Q, Popkin D.

Immunotherapy (Los Angel). 2015 Dec;1(1). pii: 104. Epub 2015 Nov 30.

3.

Network Meta-analysis of Treatments for Chronic Plaque Psoriasis in Canada.

Gupta AK, Daigle D, Lyons DC.

J Cutan Med Surg. 2014 Nov;18(6):371-8. Review.

PMID:
25348757
4.

Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.

Lebre MC, Jonckheere CL, Kraan MC, van Kuijk AW, Bos JD, de Rie M, Gerlag DM, Tak PP.

Arthritis Res Ther. 2012 Sep 24;14(5):R200. doi: 10.1186/ar4038.

5.

Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study.

Bhutani T, Kamangar F, Zitelli K, Chiang C, Gattu S, Nguyen T, Becker E, Koo J.

J Dermatolog Treat. 2013 Oct;24(5):348-50. doi: 10.3109/09546634.2012.672712. Epub 2012 Jun 5.

PMID:
22506829
6.

Iatrogenic effects of biologics for psoriasis.

Stevenson ML, Lebwohl M.

Clin Dermatol. 2011 Nov-Dec;29(6):614-21. doi: 10.1016/j.clindermatol.2011.08.002. Review.

PMID:
22014983
7.

HLA polymorphism among Chinese patients with chronic plaque psoriasis: subgroup analysis.

Chiu HY, Huang PY, Jee SH, Hu CY, Chou CT, Chang YT, Hwang CY, Tsai TF.

Br J Dermatol. 2012 Feb;166(2):288-97. doi: 10.1111/j.1365-2133.2011.10688.x. Epub 2012 Jan 9.

PMID:
21985130
8.

Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.

Inzinger M, Heschl B, Weger W, Hofer A, Legat FJ, Gruber-Wackernagel A, Tilz H, Salmhofer W, Quehenberger F, Wolf P.

Br J Dermatol. 2011 Sep;165(3):640-5. doi: 10.1111/j.1365-2133.2011.10396.x. Epub 2011 Jul 11.

PMID:
21564068
9.

Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept.

Lynde C, Krell J, Korman N, Mathes B; Vaccine Study Investigators.

J Am Acad Dermatol. 2011 Oct;65(4):799-806. doi: 10.1016/j.jaad.2010.04.040. Epub 2011 Mar 30.

PMID:
21453987
10.

Efalizumab.

Talamonti M, Spallone G, Di Stefani A, Costanzo A, Chimenti S.

Expert Opin Drug Saf. 2011 Mar;10(2):239-51. doi: 10.1517/14740338.2011.524925. Epub 2011 Jan 10. Review.

PMID:
21214420
11.

The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis.

Roberts JL, Ortonne JP, Tan JK, Jaracz E, Frankel E; Alefacept Clinical Study Group.

J Am Acad Dermatol. 2010 Jun;62(6):968-78. doi: 10.1016/j.jaad.2009.07.032. Epub 2010 Apr 14.

PMID:
20392521
12.

Alefacept treatment for chronic plaque psoriasis.

Dunn LK, Feldman SR.

Skin Therapy Lett. 2010 Apr;15(4):1-3. Review.

13.

Update on alefacept safety.

Wexler D, Searles G, Landells I, Shear NH, Bissonnette R, Papp K, Poulin Y, Langley R, Gulliver WP.

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S139-47.

PMID:
20053326
14.

Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study.

Searles G, Bissonnette R, Landells I, Shear NH, Papp K, Lui H.

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S131-8.

PMID:
20053325
15.

Efficacy outcomes in patients using alefacept in the AWARE study.

Landells I, Searles G, Bissonnette R, Shear NH, Vender R, Lui H.

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S122-30.

PMID:
20053324
16.

The AWARE study: methodology and baseline characteristics.

Bissonnette R, Searles G, Landells I, Shear NH, Papp K, Lui H, Gulliver WP, Lynde C.

J Cutan Med Surg. 2009 Dec;13 Suppl 3:S113-21.

PMID:
20053323
17.

Biologics in the treatment of psoriasis: clinical and economic overview.

Poulin Y, Langley RG, Teixeira HD, Martel MJ, Cheung S.

J Cutan Med Surg. 2009 Sep-Oct;13 Suppl 2:S49-57. Review.

PMID:
19799827
18.

Monitoring patients treated with efalizumab or alefacept.

Papp KA.

Curr Probl Dermatol. 2009;38:95-106. doi: 10.1159/000232306. Epub 2009 Jul 28. Review.

PMID:
19710552
19.

Psoriasis (chronic plaque).

Naldi L, Rzany B.

BMJ Clin Evid. 2009 Jan 9;2009. pii: 1706. Review.

20.

A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.

Krueger GG, Gottlieb AB, Sterry W, Korman N, Van De Kerkhof P.

J Dermatolog Treat. 2008;19(3):146-55. doi: 10.1080/09546630701846103.

PMID:
18569270

Supplemental Content

Loading ...
Support Center